Press Release: Immunicum Presents Phase II Data Demonstrating Reduced MRD and Improved Survival with...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2608971362

Press Release: Immunicum Presents Phase II Data Demonstrating Reduced MRD and Improved Survival with DCP-001 Treatment in AML Patients at ASH 2021

Full title

Press Release: Immunicum Presents Phase II Data Demonstrating Reduced MRD and Improved Survival with DCP-001 Treatment in AML Patients at ASH 2021

Publisher

New York: Dow Jones & Company Inc

Journal title

Dow Jones Institutional News, 2021

Language

English

Formats

Publisher

New York: Dow Jones & Company Inc

Subjects and topics

Full title

Press Release: Immunicum Presents Phase II Data Demonstrating Reduced MRD and Improved Survival with DCP-001 Treatment in AML Patients at ASH 2021

Record Identifier

TN_cdi_proquest_wirefeeds_2608971362

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2608971362

Log in as a Library member

Celebrating and sharing stories of Indigenous Australia, and helping to locate and prioritise Indigenous voices in the Library's collections.

Resources and programs for school and university students, teachers, families and lifelong learners.

Showcasing people, places and ideas inspired by the collection and the library community.